US5912015A
(en)
*
|
1992-03-12 |
1999-06-15 |
Alkermes Controlled Therapeutics, Inc. |
Modulated release from biocompatible polymers
|
US6514533B1
(en)
|
1992-06-11 |
2003-02-04 |
Alkermas Controlled Therapeutics, Inc. |
Device for the sustained release of aggregation-stabilized, biologically active agent
|
DK0674506T3
(da)
*
|
1992-12-02 |
2001-01-08 |
Alkermes Inc |
Væksthormonholdige mikrosfærer med styret frigivelse
|
US6090925A
(en)
|
1993-03-09 |
2000-07-18 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
US5981719A
(en)
|
1993-03-09 |
1999-11-09 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
US6369116B1
(en)
*
|
1995-06-02 |
2002-04-09 |
Oculex Pharmaceuticals, Inc. |
Composition and method for treating glaucoma
|
US20060280774A1
(en)
*
|
1995-06-02 |
2006-12-14 |
Allergan, Inc. |
Compositions and methods for treating glaucoma
|
US5869079A
(en)
*
|
1995-06-02 |
1999-02-09 |
Oculex Pharmaceuticals, Inc. |
Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
|
JP2001515457A
(ja)
*
|
1995-06-07 |
2001-09-18 |
アルカームズ コントロールド セラピューティックス,インコーポレイテッド |
凝集安定化生理活性物質放出用装置
|
EP1080718A1
(de)
*
|
1995-06-07 |
2001-03-07 |
Alkermes Controlled Therapeutics, Inc. |
Zusammensetzung zur verzögerten Abgabe von menschlichem Wachstumshormon
|
PL184531B1
(pl)
*
|
1995-06-07 |
2002-11-29 |
Alkermes Inc |
Kompozycja o opóźnionym uwalnianiu ludzkiego hormonu wzrostu do wytwarzania leku do terapii
|
WO1997001331A2
(en)
|
1995-06-27 |
1997-01-16 |
Takeda Chemical Industries, Ltd. |
Method of producing sustained-release preparation
|
US6265389B1
(en)
|
1995-08-31 |
2001-07-24 |
Alkermes Controlled Therapeutics, Inc. |
Microencapsulation and sustained release of oligonucleotides
|
JP2000507912A
(ja)
*
|
1995-08-31 |
2000-06-27 |
アルカームズ コントロールド セラピューティックス,インコーポレイテッド |
作用剤の徐放性組成物
|
US6270795B1
(en)
|
1995-11-09 |
2001-08-07 |
Microbiological Research Authority |
Method of making microencapsulated DNA for vaccination and gene therapy
|
US5980948A
(en)
*
|
1996-08-16 |
1999-11-09 |
Osteotech, Inc. |
Polyetherester copolymers as drug delivery matrices
|
US5952226A
(en)
*
|
1996-11-05 |
1999-09-14 |
Modex Therapeutiques |
Hypoxia responsive EPO producing cells
|
US20070185032A1
(en)
*
|
1996-12-11 |
2007-08-09 |
Praecis Pharmaceuticals, Inc. |
Pharmaceutical formulations for sustained drug delivery
|
US5968895A
(en)
*
|
1996-12-11 |
1999-10-19 |
Praecis Pharmaceuticals, Inc. |
Pharmaceutical formulations for sustained drug delivery
|
WO1998027980A2
(en)
*
|
1996-12-20 |
1998-07-02 |
Takeda Chemical Industries, Ltd. |
Method of producing a sustained-release preparation
|
ES2256898T3
(es)
|
1996-12-20 |
2006-07-16 |
Alza Corporation |
Composicion de gel y procedimientos.
|
US20020182258A1
(en)
*
|
1997-01-22 |
2002-12-05 |
Zycos Inc., A Delaware Corporation |
Microparticles for delivery of nucleic acid
|
US6656508B2
(en)
|
1997-04-17 |
2003-12-02 |
Amgen Inc. |
Sustained-release alginate gels
|
US6020004A
(en)
*
|
1997-04-17 |
2000-02-01 |
Amgen Inc. |
Biodegradable microparticles for the sustained delivery of therapeutic drugs
|
AU1552502A
(en)
*
|
1997-05-16 |
2002-03-28 |
Amgen, Inc. |
Sustained-release delayed gels
|
US6531154B1
(en)
|
1997-06-10 |
2003-03-11 |
Brown University Research Foundation |
Modulated release from biocompatible polymers
|
KR100220645B1
(ko)
*
|
1997-07-04 |
1999-09-15 |
구광시 |
벤젠유도체의 제조방법
|
US6153210A
(en)
*
|
1997-08-14 |
2000-11-28 |
Periodontix, Inc. |
Use of locally delivered metal ions for treatment of periodontal disease
|
AU760034B2
(en)
|
1997-08-29 |
2003-05-08 |
Corixa Corporation |
Rapid release encapsulated bioactive agents for inducing or potentiating an immune response and methods of using thereof
|
US5989463A
(en)
*
|
1997-09-24 |
1999-11-23 |
Alkermes Controlled Therapeutics, Inc. |
Methods for fabricating polymer-based controlled release devices
|
US6191107B1
(en)
|
1997-09-26 |
2001-02-20 |
Takeda Chemical Industries, Ltd. |
Complex of human growth hormone and zinc
|
US6565885B1
(en)
|
1997-09-29 |
2003-05-20 |
Inhale Therapeutic Systems, Inc. |
Methods of spray drying pharmaceutical compositions
|
US6309623B1
(en)
|
1997-09-29 |
2001-10-30 |
Inhale Therapeutic Systems, Inc. |
Stabilized preparations for use in metered dose inhalers
|
US20020017295A1
(en)
*
|
2000-07-07 |
2002-02-14 |
Weers Jeffry G. |
Phospholipid-based powders for inhalation
|
US20060165606A1
(en)
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
US6183746B1
(en)
|
1997-10-09 |
2001-02-06 |
Zycos Inc. |
Immunogenic peptides from the HPV E7 protein
|
US6013258A
(en)
*
|
1997-10-09 |
2000-01-11 |
Zycos Inc. |
Immunogenic peptides from the HPV E7 protein
|
US6270464B1
(en)
|
1998-06-22 |
2001-08-07 |
Artemis Medical, Inc. |
Biopsy localization method and device
|
KR20010086245A
(ko)
|
1998-03-04 |
2001-09-10 |
다케다 야쿠힌 고교 가부시키가이샤 |
Aⅱ 길항제용 서방성 제제, 그것의 제조 및 용도
|
US6096726A
(en)
|
1998-03-11 |
2000-08-01 |
Surface Solutions Laboratories Incorporated |
Multicomponent complex for use with substrate
|
US6432449B1
(en)
*
|
1998-05-18 |
2002-08-13 |
Amgen Inc. |
Biodegradable sustained-release alginate gels
|
US6248057B1
(en)
|
1998-07-28 |
2001-06-19 |
Innerdyne, Inc. |
Absorbable brachytherapy and chemotherapy delivery devices and methods
|
WO2000030532A1
(en)
*
|
1998-11-20 |
2000-06-02 |
University Of Connecticut |
Generic integrated implantable potentiostat telemetry unit for electrochemical sensors
|
US6800329B2
(en)
*
|
1999-02-12 |
2004-10-05 |
Lts Lohmann Therapie-Systeme Ag |
Method for producing film-type dosage
|
DE19905801B4
(de)
*
|
1999-02-12 |
2008-03-13 |
Lts Lohmann Therapie-Systeme Ag |
Verfahren zur Herstellung folienförmiger Darreichungsformen
|
US6451347B1
(en)
|
1999-03-01 |
2002-09-17 |
Alkermes Controlled Therapeutics, Inc. |
Method for purifying human growth hormone
|
US6444223B1
(en)
|
1999-05-28 |
2002-09-03 |
Alkermes Controlled Therapeutics, Inc. |
Method of producing submicron particles of a labile agent and use thereof
|
AU779277B2
(en)
*
|
1999-06-04 |
2005-01-13 |
Alza Corporation |
Implantable gel compositions and method of manufacture
|
EP1949890A3
(de)
|
1999-06-04 |
2011-05-18 |
ALZA Corporation |
Implantierbare Gelzusammensetzungen und Herstellungsverfahren dafür
|
US6555139B2
(en)
|
1999-06-28 |
2003-04-29 |
Wockhardt Europe Limited |
Preparation of micron-size pharmaceutical particles by microfluidization
|
DE19940238A1
(de)
*
|
1999-08-25 |
2001-03-01 |
Lohmann Therapie Syst Lts |
Wirkstoffhaltiges therapeutisches System zur Applikation auf der Haut mit mindestens zwei polymerhaltigen Schichten
|
US20050100928A1
(en)
*
|
1999-09-16 |
2005-05-12 |
Zycos Inc., A Delaware Corporation |
Nucleic acids encoding polyepitope polypeptides
|
CN1384751A
(zh)
|
1999-09-17 |
2002-12-11 |
武田药品工业株式会社 |
蛋白粉生产方法
|
US7651703B2
(en)
|
1999-10-15 |
2010-01-26 |
Genentech, Inc. |
Injection vehicle for polymer-based formulations
|
US7582311B1
(en)
|
1999-10-15 |
2009-09-01 |
Genentech, Inc. |
Injection vehicle for polymer-based formulations
|
US6284283B1
(en)
|
1999-10-21 |
2001-09-04 |
Alkermes Controlled Therapeutics, Inc. |
Method of producing sub-micron particles of biologically active agents and uses thereof
|
US20050037086A1
(en)
*
|
1999-11-19 |
2005-02-17 |
Zycos Inc., A Delaware Corporation |
Continuous-flow method for preparing microparticles
|
US6743446B2
(en)
|
1999-12-15 |
2004-06-01 |
The Ohio State University Research Foundation |
Methods for stabilizing biologically active agents encapsulated in biodegradable controlled-release polymers
|
US20040071715A1
(en)
*
|
1999-12-15 |
2004-04-15 |
Schwendeman Steven P. |
Polymer compositions that stabilize and control the release of formaldehyde-treated vaccine antigens
|
US6575888B2
(en)
|
2000-01-25 |
2003-06-10 |
Biosurface Engineering Technologies, Inc. |
Bioabsorbable brachytherapy device
|
US6465425B1
(en)
*
|
2000-02-10 |
2002-10-15 |
Alkermes Controlled Therapeutics, Inc. |
Microencapsulation and sustained release of biologically active acid-stable or free sulfhydryl-containing proteins
|
AU4743601A
(en)
|
2000-03-15 |
2001-09-24 |
Wolfgang Sadee |
Neutral antagonists and use thereof in treating drug abuse
|
US20030211974A1
(en)
*
|
2000-03-21 |
2003-11-13 |
Brodbeck Kevin J. |
Gel composition and methods
|
US8404217B2
(en)
|
2000-05-10 |
2013-03-26 |
Novartis Ag |
Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
US7442388B2
(en)
|
2000-05-10 |
2008-10-28 |
Weers Jeffry G |
Phospholipid-based powders for drug delivery
|
US6264987B1
(en)
*
|
2000-05-19 |
2001-07-24 |
Alkermes Controlled Therapeutics Inc. Ii |
Method for preparing microparticles having a selected polymer molecular weight
|
US6495164B1
(en)
|
2000-05-25 |
2002-12-17 |
Alkermes Controlled Therapeutics, Inc. I |
Preparation of injectable suspensions having improved injectability
|
AU6815901A
(en)
*
|
2000-06-02 |
2001-12-17 |
Zycos Inc |
Delivery systems for bioactive agents
|
US6726918B1
(en)
|
2000-07-05 |
2004-04-27 |
Oculex Pharmaceuticals, Inc. |
Methods for treating inflammation-mediated conditions of the eye
|
US6719970B1
(en)
*
|
2000-07-10 |
2004-04-13 |
Alkermes Controlled Therapeutics, Inc. |
Method of generating cartilage
|
US20040158317A1
(en)
*
|
2000-07-18 |
2004-08-12 |
Pharmasonics, Inc. |
Coated stent with ultrasound therapy
|
US6479065B2
(en)
|
2000-08-10 |
2002-11-12 |
Alkermes Controlled Therapeutics, Inc. |
Process for the preparation of polymer-based sustained release compositions
|
US6296842B1
(en)
|
2000-08-10 |
2001-10-02 |
Alkermes Controlled Therapeutics, Inc. |
Process for the preparation of polymer-based sustained release compositions
|
US6824822B2
(en)
*
|
2001-08-31 |
2004-11-30 |
Alkermes Controlled Therapeutics Inc. Ii |
Residual solvent extraction method and microparticles produced thereby
|
US6666541B2
(en)
*
|
2000-09-25 |
2003-12-23 |
Picoliter Inc. |
Acoustic ejection of fluids from a plurality of reservoirs
|
US6471995B1
(en)
|
2000-09-27 |
2002-10-29 |
Alkermes Controlled Therapeutics, Inc. Ii |
Apparatus and method for preparing microparticles using liquid-liquid extraction
|
DE60114229T2
(de)
|
2000-11-29 |
2006-07-06 |
Allergan, Inc., Irvine |
Verhinderung von transplantatabstossung im auge
|
US7018405B2
(en)
|
2000-12-22 |
2006-03-28 |
Avantec Vascular Corporation |
Intravascular delivery of methylprednisolone
|
US20030050692A1
(en)
*
|
2000-12-22 |
2003-03-13 |
Avantec Vascular Corporation |
Delivery of therapeutic capable agents
|
US7083642B2
(en)
*
|
2000-12-22 |
2006-08-01 |
Avantec Vascular Corporation |
Delivery of therapeutic capable agents
|
US20020082678A1
(en)
*
|
2000-12-22 |
2002-06-27 |
Motasim Sirhan |
Intravascular delivery of mizoribine
|
US20050203612A1
(en)
*
|
2000-12-22 |
2005-09-15 |
Avantec Vascular Corporation |
Devices delivering therapeutic agents and methods regarding the same
|
US20030033007A1
(en)
*
|
2000-12-22 |
2003-02-13 |
Avantec Vascular Corporation |
Methods and devices for delivery of therapeutic capable agents with variable release profile
|
US6939375B2
(en)
|
2000-12-22 |
2005-09-06 |
Avantac Vascular Corporation |
Apparatus and methods for controlled substance delivery from implanted prostheses
|
US6471980B2
(en)
|
2000-12-22 |
2002-10-29 |
Avantec Vascular Corporation |
Intravascular delivery of mycophenolic acid
|
US7077859B2
(en)
|
2000-12-22 |
2006-07-18 |
Avantec Vascular Corporation |
Apparatus and methods for variably controlled substance delivery from implanted prostheses
|
US20020114843A1
(en)
*
|
2000-12-27 |
2002-08-22 |
Ramstack J. Michael |
Preparation of microparticles having improved flowability
|
US8637077B2
(en)
|
2000-12-28 |
2014-01-28 |
Takeda Pharmaceutical Company Limited |
Sustained-release preparation
|
US20060269602A1
(en)
*
|
2001-04-13 |
2006-11-30 |
Dasch James R |
Method of modifying the release profile of sustained release compositions
|
US6558702B2
(en)
*
|
2001-04-13 |
2003-05-06 |
Alkermes Controlled Therapeutics, Inc. |
Method of modifying the release profile of sustained release compositions
|
US6537195B2
(en)
|
2001-05-07 |
2003-03-25 |
Xoft, Microtube, Inc. |
Combination x-ray radiation and drug delivery devices and methods for inhibiting hyperplasia
|
US7018371B2
(en)
*
|
2001-05-07 |
2006-03-28 |
Xoft, Inc. |
Combination ionizing radiation and radiosensitizer delivery devices and methods for inhibiting hyperplasia
|
HUP0400264A2
(hu)
*
|
2001-06-22 |
2004-08-30 |
Pfizer Products Inc. |
Alacsony oldékonyságú és/vagy savra érzékeny hatóanyagokat és semlegesített savas polimereket tartalmazó gyógyszerkészítmények és eljárás az előállításukra
|
ATE444060T1
(de)
|
2001-06-22 |
2009-10-15 |
Pfizer Prod Inc |
Pharmazeutische zusammensetzungen enthaltend dispersionen aus arzneistoffen und neutralen polymeren
|
ES2278952T3
(es)
*
|
2001-07-26 |
2007-08-16 |
Avantec Vascular Corporation |
Dispositivos para administrar agentes terapeuticos con perfil de liberacion variable.
|
DK1455593T3
(da)
|
2001-10-06 |
2013-08-26 |
Merial Ltd |
Fremgangsmåder og sammensætninger til fremme af vækst og medfødt immunitet hos unge dyr
|
US20070281003A1
(en)
|
2001-10-12 |
2007-12-06 |
Fuisz Richard C |
Polymer-Based Films and Drug Delivery Systems Made Therefrom
|
US8765167B2
(en)
|
2001-10-12 |
2014-07-01 |
Monosol Rx, Llc |
Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
|
US20110033542A1
(en)
|
2009-08-07 |
2011-02-10 |
Monosol Rx, Llc |
Sublingual and buccal film compositions
|
US8603514B2
(en)
|
2002-04-11 |
2013-12-10 |
Monosol Rx, Llc |
Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
|
US11207805B2
(en)
|
2001-10-12 |
2021-12-28 |
Aquestive Therapeutics, Inc. |
Process for manufacturing a resulting pharmaceutical film
|
US20190328679A1
(en)
|
2001-10-12 |
2019-10-31 |
Aquestive Therapeutics, Inc. |
Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
|
US10285910B2
(en)
|
2001-10-12 |
2019-05-14 |
Aquestive Therapeutics, Inc. |
Sublingual and buccal film compositions
|
US8900497B2
(en)
|
2001-10-12 |
2014-12-02 |
Monosol Rx, Llc |
Process for making a film having a substantially uniform distribution of components
|
US8900498B2
(en)
|
2001-10-12 |
2014-12-02 |
Monosol Rx, Llc |
Process for manufacturing a resulting multi-layer pharmaceutical film
|
US7357891B2
(en)
|
2001-10-12 |
2008-04-15 |
Monosol Rx, Llc |
Process for making an ingestible film
|
US20070196415A1
(en)
*
|
2002-11-14 |
2007-08-23 |
Guohua Chen |
Depot compositions with multiple drug release rate controls and uses thereof
|
IL162000A0
(en)
*
|
2001-11-14 |
2005-11-20 |
Alza Corp |
Injectable depot compositions and use thereof
|
ATE502621T1
(de)
*
|
2001-11-14 |
2011-04-15 |
Durect Corp |
Katheterinjizierbare depotzusammensetzungen und deren verwendung
|
EP1458360B1
(de)
|
2001-12-19 |
2011-05-11 |
Novartis AG |
Pulmonale verabreichung von aminoglykosiden
|
EP1478648B1
(de)
|
2002-02-01 |
2014-04-30 |
ARIAD Pharmaceuticals, Inc. |
Phosphorhaltige verbindungen und deren verwendungen
|
US20040001889A1
(en)
|
2002-06-25 |
2004-01-01 |
Guohua Chen |
Short duration depot formulations
|
TWI353854B
(en)
|
2002-06-25 |
2011-12-11 |
Alza Corp |
Short duration depot formulations
|
NZ537955A
(en)
*
|
2002-07-31 |
2007-10-26 |
Alza Corp |
Injectable depot compositions and uses thereof
|
BR0313539A
(pt)
|
2002-07-31 |
2005-06-21 |
Alza Corp |
Composições depósito de polìmero multimodais injetáveis e seus usos
|
AU2003282955A1
(en)
*
|
2002-10-17 |
2004-05-04 |
Alkermes Controlled Therapeutics, Inc. Ii |
Microencapsulation and sustained release of biologically active polypeptides
|
DE60332377D1
(de)
*
|
2002-10-21 |
2010-06-10 |
Eisai Inc |
Zusammensetzungen und verfahren zurbehandlung von krankheiten, die durch das humane papillomavirus vermitteltwerden
|
AU2003295409B2
(en)
*
|
2002-11-06 |
2010-02-11 |
Durect Corporation |
Controlled release depot formulations
|
US20050048099A1
(en)
|
2003-01-09 |
2005-03-03 |
Allergan, Inc. |
Ocular implant made by a double extrusion process
|
US20050112087A1
(en)
*
|
2003-04-29 |
2005-05-26 |
Musso Gary F. |
Pharmaceutical formulations for sustained drug delivery
|
US20060193825A1
(en)
*
|
2003-04-29 |
2006-08-31 |
Praecis Phamaceuticals, Inc. |
Pharmaceutical formulations for sustained drug delivery
|
CN1822816A
(zh)
*
|
2003-05-30 |
2006-08-23 |
阿尔萨公司 |
可植入的弹性体储库组合物、其用途以及制备方法
|
US20070184084A1
(en)
*
|
2003-05-30 |
2007-08-09 |
Guohua Chen |
Implantable elastomeric caprolactone depot compositions and uses thereof
|
US20070224278A1
(en)
|
2003-11-12 |
2007-09-27 |
Lyons Robert T |
Low immunogenicity corticosteroid compositions
|
US20050101582A1
(en)
|
2003-11-12 |
2005-05-12 |
Allergan, Inc. |
Compositions and methods for treating a posterior segment of an eye
|
US20050106214A1
(en)
*
|
2003-11-14 |
2005-05-19 |
Guohua Chen |
Excipients in drug delivery vehicles
|
US20050118206A1
(en)
*
|
2003-11-14 |
2005-06-02 |
Luk Andrew S. |
Surfactant-based gel as an injectable, sustained drug delivery vehicle
|
US20050281879A1
(en)
*
|
2003-11-14 |
2005-12-22 |
Guohua Chen |
Excipients in drug delivery vehicles
|
WO2005051229A2
(en)
*
|
2003-11-24 |
2005-06-09 |
Avantec Vascular Corporation |
Devices delivering therapeutic agents and methods regarding the same
|
EP1706095B1
(de)
|
2004-01-20 |
2008-12-24 |
Allergan, Inc. |
Zusammensetzungen für die lokalisierte therapie des auges, vorzugsweise enthaltend triamcinolon-acetonid und hyaluronsäure
|
WO2005082405A1
(ja)
*
|
2004-02-26 |
2005-09-09 |
Japan Science And Technology Agency |
たんぱく性薬物の注射用徐放性微粒子製剤およびその製造法
|
JP5030292B2
(ja)
*
|
2004-04-15 |
2012-09-19 |
アミリン・ファーマシューティカルズ,インコーポレイテッド |
ポリマーを基にした持続放出性装置
|
US7456254B2
(en)
*
|
2004-04-15 |
2008-11-25 |
Alkermes, Inc. |
Polymer-based sustained release device
|
US20060110423A1
(en)
*
|
2004-04-15 |
2006-05-25 |
Wright Steven G |
Polymer-based sustained release device
|
CA2563957A1
(en)
*
|
2004-04-23 |
2005-11-10 |
Amgen Inc. |
Low molecular weight polylactic acid polymers
|
US8591885B2
(en)
*
|
2004-04-30 |
2013-11-26 |
Allergan, Inc. |
Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems
|
US20050244469A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Extended therapeutic effect ocular implant treatments
|
US8455656B2
(en)
|
2004-04-30 |
2013-06-04 |
Allergan, Inc. |
Kinase inhibitors
|
US20050244458A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Sustained release intraocular implants and methods for treating ocular neuropathies
|
US8673341B2
(en)
|
2004-04-30 |
2014-03-18 |
Allergan, Inc. |
Intraocular pressure reduction with intracameral bimatoprost implants
|
US20050244471A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Estradiol derivative and estratopone containing sustained release intraocular implants and related methods
|
US20050244462A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Devices and methods for treating a mammalian eye
|
US8425929B2
(en)
*
|
2004-04-30 |
2013-04-23 |
Allergan, Inc. |
Sustained release intraocular implants and methods for preventing retinal dysfunction
|
US8722097B2
(en)
|
2004-04-30 |
2014-05-13 |
Allergan, Inc. |
Oil-in-water method for making polymeric implants containing a hypotensive lipid
|
US8147865B2
(en)
|
2004-04-30 |
2012-04-03 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
US20050244478A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Anti-excititoxic sustained release intraocular implants and related methods
|
US20050244463A1
(en)
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Sustained release intraocular implants and methods for treating ocular vasculopathies
|
US7993634B2
(en)
|
2004-04-30 |
2011-08-09 |
Allergan, Inc. |
Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods
|
US20050244466A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Photodynamic therapy in conjunction with intraocular implants
|
US20050244461A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Controlled release drug delivery systems and methods for treatment of an eye
|
US7799336B2
(en)
|
2004-04-30 |
2010-09-21 |
Allergan, Inc. |
Hypotensive lipid-containing biodegradable intraocular implants and related methods
|
US7771742B2
(en)
|
2004-04-30 |
2010-08-10 |
Allergan, Inc. |
Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods
|
BRPI0510485A
(pt)
|
2004-04-30 |
2007-11-13 |
Allergan Inc |
implantes inibidores de tirosina cinase intravìtreos biodegradáveis
|
US9498457B2
(en)
|
2004-04-30 |
2016-11-22 |
Allergan, Inc. |
Hypotensive prostamide-containing biodegradable intraocular implants and related implants
|
US8119154B2
(en)
*
|
2004-04-30 |
2012-02-21 |
Allergan, Inc. |
Sustained release intraocular implants and related methods
|
US20070059336A1
(en)
*
|
2004-04-30 |
2007-03-15 |
Allergan, Inc. |
Anti-angiogenic sustained release intraocular implants and related methods
|
WO2005107714A2
(en)
*
|
2004-05-05 |
2005-11-17 |
Alkermes Controlled Therapeutics, Inc. |
Method of forming microparticles that include a bisphosphonate and a polymer
|
ES2432556T3
(es)
|
2004-08-04 |
2013-12-04 |
Evonik Corporation |
Métodos para fabricar dispositivos de suministro y sus dispositivos
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
CA2619426C
(en)
|
2005-08-19 |
2016-06-21 |
Amylin Pharmaceuticals, Inc. |
Exendin for treating diabetes and reducing body weight
|
US20070178138A1
(en)
*
|
2006-02-01 |
2007-08-02 |
Allergan, Inc. |
Biodegradable non-opthalmic implants and related methods
|
US8802128B2
(en)
*
|
2006-06-23 |
2014-08-12 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
US20070298073A1
(en)
*
|
2006-06-23 |
2007-12-27 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
PL2359808T3
(pl)
|
2006-08-09 |
2013-10-31 |
Intarcia Therapeutics Inc |
Osmotyczne systemy dostawcze i zespoły tłokowe
|
US8969415B2
(en)
|
2006-12-01 |
2015-03-03 |
Allergan, Inc. |
Intraocular drug delivery systems
|
JP2010517703A
(ja)
|
2007-02-09 |
2010-05-27 |
タヘリ ラドュカ エルエルシー |
血管移植片およびそれを加工する方法
|
ZA200801724B
(en)
*
|
2007-02-23 |
2009-07-29 |
Univ Witwatersrand Jhb |
An improved monolithic drug delivery system
|
AU2008231093A1
(en)
*
|
2007-03-22 |
2008-10-02 |
Alkermes, Inc. |
Coacervation process
|
US7911053B2
(en)
*
|
2007-04-19 |
2011-03-22 |
Marvell World Trade Ltd. |
Semiconductor packaging with internal wiring bus
|
AU2008244523B2
(en)
|
2007-04-23 |
2012-02-16 |
Intarcia Therapeutics, Inc. |
Suspension formulations of insulinotropic peptides and uses thereof
|
WO2008157540A1
(en)
*
|
2007-06-20 |
2008-12-24 |
Alkermes, Inc. |
Quench liquids and washing systems for production of microparticles
|
US8748448B2
(en)
|
2007-10-18 |
2014-06-10 |
Aiko Biotechnology |
Combination analgesic employing opioid agonist and neutral antagonist
|
EP2214672B1
(de)
*
|
2007-10-18 |
2012-10-17 |
Aiko Biotechnology |
Kombinationsanalgetikum mit einem opioid und einem neutralen antagonisten
|
EP2222281B1
(de)
|
2007-12-20 |
2018-12-05 |
Evonik Corporation |
Verfahren zur herstellung von mikropartikeln mit geringer restlösemittelmenge
|
WO2009102467A2
(en)
|
2008-02-13 |
2009-08-20 |
Intarcia Therapeutics, Inc. |
Devices, formulations, and methods for delivery of multiple beneficial agents
|
GB0810990D0
(en)
|
2008-06-16 |
2008-07-23 |
Q Chip Ltd |
Device and method of making solid beads
|
EP2389160B1
(de)
*
|
2009-01-23 |
2017-09-13 |
Evonik Corporation |
Kontinuierliches doppelemulsionsverfahren zur herstellung von mikroteilchen
|
KR102093612B1
(ko)
|
2009-09-28 |
2020-03-26 |
인타르시아 세라퓨틱스 인코포레이티드 |
실질 항정상태 약물 전달의 신속 확립 및/또는 종결
|
MY160217A
(en)
|
2009-11-09 |
2017-02-28 |
Allergan Inc |
Compositions and methods for stimulating hair growth
|
LT2394663T
(lt)
*
|
2010-05-31 |
2022-02-10 |
Laboratorios Farmaceuticos Rovi, S.A. |
Kompozicijos, skirtos įšvirkščiamiems in situ biologiškai skaidiems implantams
|
PL2394664T3
(pl)
*
|
2010-05-31 |
2016-12-30 |
|
Preparat przeciwpsychotyczny do wstrzykiwań o przedłużonym uwalnianiu
|
US10463607B2
(en)
|
2010-05-31 |
2019-11-05 |
Laboratorios Farmaceutics Rofi S.A. |
Antipsychotic Injectable Depot Composition
|
WO2012038801A1
(en)
|
2010-09-21 |
2012-03-29 |
National Institute Of Immunology |
A spray dried powder formulation for vaccines entrapping alum and the antigen in biodegradable polymer particles
|
US9149959B2
(en)
|
2010-10-22 |
2015-10-06 |
Monosol Rx, Llc |
Manufacturing of small film strips
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
ES2925534T3
(es)
|
2011-11-05 |
2022-10-18 |
South Alabama Medical Science Found |
Métodos, formulaciones y kits para reponer rápidamente los niveles de folato en mujeres
|
US20130122096A1
(en)
*
|
2011-11-14 |
2013-05-16 |
Silenseed Ltd. |
Compositions for drug delivery and methods of manufacturing and using same
|
JP6511401B2
(ja)
|
2013-02-15 |
2019-05-15 |
アラーガン、インコーポレイテッドAllergan,Incorporated |
持続型薬物送達インプラント
|
JP6564369B2
(ja)
|
2013-12-09 |
2019-08-21 |
デュレクト コーポレイション |
薬学的活性剤複合体、ポリマー複合体、ならびにこれらを伴う組成物及び方法
|
US10166725B2
(en)
|
2014-09-08 |
2019-01-01 |
Holo, Inc. |
Three dimensional printing adhesion reduction using photoinhibition
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
EP3291838A4
(de)
*
|
2015-05-05 |
2019-01-02 |
B.G. Negev Technologies and Applications Ltd. |
Anionische nanopartikel zur verwendung bei der abgabe von anionischen kleinmolekularen arzneimitteln
|
KR20240042548A
(ko)
|
2015-06-03 |
2024-04-02 |
인타르시아 세라퓨틱스 인코포레이티드 |
임플란트 배치 및 제거 시스템들
|
US11141919B2
(en)
|
2015-12-09 |
2021-10-12 |
Holo, Inc. |
Multi-material stereolithographic three dimensional printing
|
US11273131B2
(en)
|
2016-05-05 |
2022-03-15 |
Aquestive Therapeutics, Inc. |
Pharmaceutical compositions with enhanced permeation
|
CA3022840A1
(en)
|
2016-05-05 |
2017-11-09 |
Aquestive Therapeutics, Inc. |
Enhanced delivery epinephrine compositions
|
TWI814219B
(zh)
|
2016-05-16 |
2023-09-01 |
美商因塔希亞治療公司 |
升糖素受體選擇性多肽和彼之使用方法
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
IL267736B2
(en)
|
2017-01-03 |
2024-03-01 |
Intarcia Therapeutics Inc |
Methods involving continuous administration of a GLP-1 receptor agonist and co-administration of a drug
|
WO2018158311A1
(en)
|
2017-02-28 |
2018-09-07 |
University College Cork - National University Of Ireland, Cork |
An intravascular cell therapy device
|
US10935891B2
(en)
|
2017-03-13 |
2021-03-02 |
Holo, Inc. |
Multi wavelength stereolithography hardware configurations
|
GB2564956B
(en)
|
2017-05-15 |
2020-04-29 |
Holo Inc |
Viscous film three-dimensional printing systems and methods
|
US10245785B2
(en)
|
2017-06-16 |
2019-04-02 |
Holo, Inc. |
Methods for stereolithography three-dimensional printing
|
CN117067579A
(zh)
|
2018-12-26 |
2023-11-17 |
霍洛公司 |
用于三维打印系统和方法的传感器
|
CN115666621A
(zh)
|
2020-01-13 |
2023-01-31 |
度勒科特公司 |
具有减少的杂质的持续释放药物递送系统及相关方法
|
TW202313047A
(zh)
|
2021-09-21 |
2023-04-01 |
西班牙商禾霏藥品實驗室有限公司 |
抗精神病可注射儲積型組合物
|